Clin Osteol 2018; 23(1): 18-27

Postmenopausal osteoporosis: standard diagnostic and therapeutic practiceGuidelines

Payer Juraj; Killinger Zdenko; Jackuliak Peter; Kužma Martin
V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava; Spoločnosť pre osteoporózu a metabolické ochorenia kostí

The Ministry of Health in cooperation with specialists has been actively engaged in the creation of standard preventive, diagnostic and therapeutic procedures. The standard diagnostic and therapeutic procedures provide a rough guide to the treatment for a diagnosis in question. The Society for Osteoporosis and Metabolic Bone Diseases has prepared a standard diagnostic and therapeutic procedure concerning patients with postmenopausal osteoporosis.

Keywords: antiresorptive therapy; ⁠ fracture; ⁠ calcium; ⁠ treatment; ⁠ osteoanabolic therapy; ⁠ osteoporosis; ⁠ prevention; ⁠ vitamin D
Received 6. 8. 2018

Published: June 11, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Payer J, Killinger Z, Jackuliak P, Kužma M. Postmenopausal osteoporosis: standard diagnostic and therapeutic practice. Clinical Osteology. 2018;23(1):18-27.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bilezikian JP, Khan AA, Potts JT jr. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 2009; 94(2): 335-339. Go to original source...
    2. Genant HK, Wu CY, van Kuijk C et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8(9): 1137-1148. Go to original source...
    3. Hans DB, Shepherd JA, Schwartz EN et al. Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom 2008; 11(1): 188-206. Go to original source...
    4. Hernlund E, Svedbom A, Ivergard M et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013; 8 : 136. Dostupné z DOI: <http://doi:10.1007/s11657-013-0136-1>. Go to original source...
    5. Kanis JA, Borgstrom F, Compston J et al. SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 2013; 8 : 144. Dostupné z DOI: <http://doi:10.1007/s11657-013-0144-1>. Go to original source...
    6. Kanis JA, Johnell O, Oden A et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19(4): 385-397. Go to original source...
    7. Kanis JA, McCloskey EV, Johansson Het al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24(1): 23-57. Go to original source...
    8. Cosman F, de Beur SJ, LeBoff MS et al. National Osteoporosis Foundation: Clinician´s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. Osteoporos Int 2014; 25(10): 2359-2381. Go to original source...
    9. Odborné usmernenie MZ SR pre diagnostiku a liečbu osteoporózy. Vestník MZ SR, čiastka 9-16, ročník 54, zo dňa 1. marca 2006.
    10. Odborné usmernenie MZ SR pre diagnostiku a liečbu glukokortikoidmi indukovanej osteoporózy (GIOP). Vestník MZ SR, čiastka 51-53, ročník 57, zo dňa 13. novembra 2009.
    11. Odborné usmernenie MZ SR o diagnostike a liečbe pacienta po osteoporotických zlomeninách. Vestník MZ SR, čiastka 1-3, ročník 59, zo dňa 4. februára 2011.
    12. Official Positions of the International Society for Clinical Densitometry 2015. Dostupné z WWW: <http://www.iscd.org/official-positions/2015-iscd-official-positions-adult>.
    13. Payer J, Killinger Z et al. Osteoporóza. Herba: Bratislava 2012. ISBN 978-80-8971-94-1.
    14. Payer J, Borovský M (eds). Osteoporóza u vybranných ochorení. Herba: Bratislava 2014. ISBN 978-80-8963-11-93.
    15. Payer J, Brazdilova K, Jackuliak P. Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options. Drug Healthc Patient Saf 2010; 2 : 49-59. Go to original source...
    16. Saag KG, Shane E, Boonen S et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007; 357(20): 2028-2039. Go to original source...
    17. Svedbom A, Hernlund E, Ivergard M et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 2013; 8 : 137. Dostupné z DOI: http://doi:10.1007/s11657-013-0137-0>. Go to original source...
    18. Watts NB, Adler RA, Bilezikian JP et al. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012; 97(6): 1802-1822. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.